𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HPLC of Sertraline and Norsertraline in Plasma or Serum

✍ Scribed by Jignasha Patel; E. P. Spencer; R. J. Flanagan


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
329 KB
Volume
10
Category
Article
ISSN
0269-3879

No coin nor oath required. For personal study only.

✦ Synopsis


A simple method for the measurement of sertraline and norsertraline in plasma or serum suitable for use in single-dose pharmacokinetic studies has been developed. Internal standard solution, aqueous fenethazine (10 mg/L) (20 pL), and 'his buffer (2 mom), pH 10.6) (100 pL) were added to plasma (200 pL). Sertraline, norsertraline and the internal standard were extracted into methyl terr-butyl ether (200 pL) by mixing (30 s) and centrifugation (11, OOO r.p.m., 4 min). A portion (100 pL) of the extract was injected onto a Spherisorb SSSCX HPLC column (1SOx 4.6 mm id.) which was eluted with methanokwater (19+ 1) containing ammonium perchlorate (40 mmoVL), final pH 7.0. Detection was by UV monitoring (215 nm). The concentration of each analyte in each sample was calculated from the calibration graph (peak-height ratio of analyte to that of the internal standard against analyte concentration) obtained after analysis of plasma samples containing known amounts of sertraline and norsertraline. The limit of accurate measurement of the assay was 10 p&) sertraline and 20 pg/L)norsertraline. Sertraline [( lS,4S)-4-(3,4-dichlorophenyl)-1.2,3,4-tetrahydro-N-methyl-1-naphthylamine, Fig. 1) is a 1 -amino-


πŸ“œ SIMILAR VOLUMES


Determination of quercetin in human plas
✍ D. J. L. Jones; C. K. Lim; D. R. Ferry; A. Gescher πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 65 KB πŸ‘ 2 views

A reversed-phase high-performance liquid chromatographic method for the determination of quercetin in human plasma following intravenous infusion is described. Quercetin in plasma was extracted with methanol-dimethyl sulphoxide (4:1 v/v) and separated on a C18 Hypersil-BDS column with 44% (v/v) meth

Stability of amyloid-Ξ² peptides in plasm
✍ Mirko Bibl; Volker Welge; Hermann Esselmann; Jens Wiltfang πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 164 KB

## Abstract Plasma amyloid‐β peptide (AΞ²) levels have been suggested as a biomarker candidate for detecting incipient AD. AΞ² peptides are known to be sensitive to distinct preanalytical sample handling, which calls for standardised preanalytical procedures. We investigated serum and plasma samples